Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.

Keepers TR, Gomez M, Celeri C, Krause KM, Biek D, Critchley I.

Infect Dis Ther. 2017 Jun;6(2):233-243. doi: 10.1007/s40121-017-0150-5. Epub 2017 Mar 11.

2.

Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure.

Cannavino CR, Mendes RE, Sader HS, Farrell DJ, Critchley IA, Biek D, Le J, Skochko SM, Jones RN, Bradley JS.

Pediatr Infect Dis J. 2016 Jul;35(7):813-5. doi: 10.1097/INF.0000000000001171.

PMID:
27093165
3.

Effect of In Vitro Testing Parameters on Ceftazidime-Avibactam Minimum Inhibitory Concentrations.

Keepers TR, Gomez M, Biek D, Critchley I, Krause KM.

Int Sch Res Notices. 2015 May 19;2015:489547. doi: 10.1155/2015/489547. eCollection 2015.

4.

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.

Mendes RE, Costello AJ, Jacobs MR, Biek D, Critchley IA, Jones RN.

Diagn Microbiol Infect Dis. 2014 Sep;80(1):19-25. doi: 10.1016/j.diagmicrobio.2014.05.020. Epub 2014 May 24.

PMID:
24974272
5.

Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.

Mendes RE, Biek D, Critchley IA, Farrell DJ, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2014 Aug;58(8):4923-7. doi: 10.1128/AAC.02976-14. Epub 2014 May 27.

6.

Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.

Beresford E, Biek D, Jandourek A, Mawal Y, Riccobene T, Friedland HD.

Expert Rev Clin Pharmacol. 2014 Mar;7(2):123-35. doi: 10.1586/17512433.2014.884457. Epub 2014 Feb 5. Review.

PMID:
24494793
7.

In vivo efficacy of ceftaroline fosamil in a methicillin-resistant panton-valentine leukocidin-producing Staphylococcus aureus rabbit pneumonia model.

Croisier-Bertin D, Hayez D, Da Silva S, Labrousse D, Biek D, Badiou C, Dumitrescu O, Guerard P, Charles PE, Piroth L, Lina G, Vandenesch F, Chavanet P.

Antimicrob Agents Chemother. 2014;58(4):1855-61. doi: 10.1128/AAC.01707-13. Epub 2014 Jan 6.

8.

Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model.

Bhalodi AA, Crandon JL, Biek D, Nicolau DP.

Antimicrob Agents Chemother. 2012 Dec;56(12):6160-5. doi: 10.1128/AAC.01078-12. Epub 2012 Sep 17.

9.

Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.

Tong A, Tong SY, Zhang Y, Lamlertthon S, Sharma-Kuinkel BK, Rude T, Ahn SH, Ruffin F, Llorens L, Tamarana G, Biek D, Critchley I, Fowler VG Jr.

PLoS One. 2012;7(5):e37212. doi: 10.1371/journal.pone.0037212. Epub 2012 May 18.

10.

Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.

Mendes RE, Tsakris A, Sader HS, Jones RN, Biek D, McGhee P, Appelbaum PC, Kosowska-Shick K.

J Antimicrob Chemother. 2012 Jun;67(6):1321-4. doi: 10.1093/jac/dks069. Epub 2012 Mar 7.

PMID:
22398650
11.

Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.

Steed ME, Vidaillac C, Winterfield P, Biek D, Rybak MJ.

Antimicrob Agents Chemother. 2012 May;56(5):2691-5. doi: 10.1128/AAC.06185-11. Epub 2012 Feb 21.

12.

CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Friedland HD, O'Neal T, Biek D, Eckburg PB, Rank DR, Llorens L, Smith A, Witherell GW, Laudano JB, Thye D.

Antimicrob Agents Chemother. 2012 May;56(5):2231-6. doi: 10.1128/AAC.05738-11. Epub 2012 Feb 6.

13.

Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.

Antimicrob Agents Chemother. 2011 Sep;55(9):4154-60. doi: 10.1128/AAC.00315-11. Epub 2011 Jun 27.

14.

Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing.

Croisier-Bertin D, Piroth L, Charles PE, Larribeau A, Biek D, Ge Y, Chavanet P.

Antimicrob Agents Chemother. 2011 Jul;55(7):3557-63. doi: 10.1128/AAC.01773-09. Epub 2011 May 16.

15.

Review of ceftaroline fosamil microbiology: integrated FOCUS studies.

Critchley IA, Eckburg PB, Jandourek A, Biek D, Friedland HD, Thye DA.

J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii45-51. doi: 10.1093/jac/dkr098. Review.

PMID:
21482569
16.

Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Jacqueline C, Amador G, Batard E, Le Mabecque V, Miègeville AF, Biek D, Caillon J, Potel G.

J Antimicrob Chemother. 2011 Apr;66(4):863-6. doi: 10.1093/jac/dkr019. Epub 2011 Jan 31.

PMID:
21393213
17.

Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.

Biek D, Critchley IA, Riccobene TA, Thye DA.

J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv9-16. doi: 10.1093/jac/dkq251. Review.

PMID:
21115457
18.

Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model.

Jacqueline C, Caillon J, Batard E, Le Mabecque V, Amador G, Ge Y, Biek D, Potel G.

J Antimicrob Chemother. 2010 Oct;65(10):2264-5. doi: 10.1093/jac/dkq328. Epub 2010 Aug 17. No abstract available.

PMID:
20716553
19.

Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.

Jacqueline C, Amador G, Caillon J, Le Mabecque V, Batard E, Miègeville AF, Biek D, Ge Y, Potel G, Hamel A.

J Antimicrob Chemother. 2010 Aug;65(8):1749-52. doi: 10.1093/jac/dkq193. Epub 2010 Jun 8.

PMID:
20530506
20.

Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.

Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley IA, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2010 Jun;54(6):2716-9. doi: 10.1128/AAC.01797-09. Epub 2010 Mar 22.

21.

In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin.

Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Ge Y, Biek D, Batard E, Potel G.

Antimicrob Agents Chemother. 2009 Dec;53(12):5300-2. doi: 10.1128/AAC.00984-09. Epub 2009 Sep 14.

22.

ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.

Morrissey I, Biek D, Janes R.

J Antimicrob Chemother. 2009 Jul;64(1):209-10. doi: 10.1093/jac/dkp163. Epub 2009 May 9. No abstract available.

PMID:
19429928
23.

In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.

McGee L, Biek D, Ge Y, Klugman M, du Plessis M, Smith AM, Beall B, Whitney CG, Klugman KP.

Antimicrob Agents Chemother. 2009 Feb;53(2):552-6. doi: 10.1128/AAC.01324-08. Epub 2008 Nov 17.

24.

In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.

Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.

Antimicrob Agents Chemother. 2008 Nov;52(11):4209-10. doi: 10.1128/AAC.00712-08. Epub 2008 Aug 25. No abstract available.

25.

In vitro activity of ME1036 versus other beta-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC.

Fenoll A, Aguilar L, Robledo O, Giménez MJ, Granizo JJ, Biek D, Tarragó D.

J Antimicrob Chemother. 2008 Nov;62(5):1156-8. doi: 10.1093/jac/dkn314. Epub 2008 Jul 30. No abstract available.

PMID:
18667449
26.

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.

Ge Y, Biek D, Talbot GH, Sahm DF.

Antimicrob Agents Chemother. 2008 Sep;52(9):3398-407. doi: 10.1128/AAC.00149-08. Epub 2008 Jul 14.

28.

Probing plasmid partition with centromere-based incompatibility.

Bouet JY, Rech J, Egloff S, Biek DP, Lane D.

Mol Microbiol. 2005 Jan;55(2):511-25.

29.

Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.

Kaczmarek FS, Zaniewski RP, Gootz TD, Danley DE, Mansour MN, Griffor M, Kamath AV, Cronan M, Mueller J, Sun D, Martin PK, Benton B, McDowell L, Biek D, Schmid MB.

J Bacteriol. 2001 May;183(10):3016-24.

30.

The F plasmid centromere, sopC, is required for full repression of the sopAB operon.

Yates P, Lane D, Biek DP.

J Mol Biol. 1999 Jul 16;290(3):627-38.

PMID:
10395819
31.

Role in cell permeability of an essential two-component system in Staphylococcus aureus.

Martin PK, Li T, Sun D, Biek DP, Schmid MB.

J Bacteriol. 1999 Jun;181(12):3666-73.

32.

A versatile low-copy-number cloning vector derived from plasmid F.

Shi J, Biek DP.

Gene. 1995 Oct 16;164(1):55-8.

PMID:
7590321
33.

Partition functions of mini-F affect plasmid DNA topology in Escherichia coli.

Biek DP, Strings J.

J Mol Biol. 1995 Feb 24;246(3):388-400.

PMID:
7877163
34.
35.
36.

High-level expression and secretion of a lysine-containing analog of Escherichia coli heat-stable enterotoxin.

Greenberg RN, Ping Z, Biek DP, Mann DM.

Protein Expr Purif. 1991 Oct-Dec;2(5-6):394-401.

PMID:
1821815
39.

Stable inheritance of bacterial plasmids: practical considerations in the release of organisms into the environment.

Cohen SN, Miller CA, Beaucage S, Biek DP.

Basic Life Sci. 1988;45:97-104. Review. No abstract available.

PMID:
3052416
40.

Identification and characterization of recD, a gene affecting plasmid maintenance and recombination in Escherichia coli.

Biek DP, Cohen SN.

J Bacteriol. 1986 Aug;167(2):594-603. Erratum in: J Bacteriol 1986 Nov;168(2):1051.

41.

Regulation of Tn5 transposition.

Biek D, Roth JR.

Cold Spring Harb Symp Quant Biol. 1981;45 Pt 1:189-91. No abstract available.

PMID:
6271465
42.

Regulation of Tn5 transposition in Salmonella typhimurium.

Biek D, Roth JR.

Proc Natl Acad Sci U S A. 1980 Oct;77(10):6047-51.

43.

A refined map of the hisG gene of Salmonella typhimurium.

Hoppe I, Johnston HM, Biek D, Roth JR.

Genetics. 1979 May;92(1):17-26.

44.

Supplemental Content

Support Center